Skip to main content
. 2015 Sep 3;13:287. doi: 10.1186/s12967-015-0655-1

Table 2.

Mutational status of the samples selected for the first (A-label) and the second (B-label) round of the EQA

Sample ID KRASa BRAFa NRASa
A1 WT WT WT
A2 WT WT WT
A3 WT WT WT
A4 WT WT WT
A5 WT WT WT
A6 WT p.V600E (c.1799T > A) (27.6 %) WT
A7 p.A146T (c.436G > A) (27.6 %) WT WT
A8 p.G12D (c.35G > A) (24.2 %) WT WT
A9 WT WT p.G12D (c.35G > A) (18.1 %)
A10 WT WT p.Q61K (c.181C > A) (74.6 %)
B1 WT WT WT
B2 WT WT WT
B3 WT WT WT
B4 WT WT WT
B5 WT WT WT
B6 p.G12D (c.35G > A) (27.7 %) WT WT
B7 p.A146T (c.436G > A) (62 %) WT WT
B8 WT WT p.Q61R (c.182A > G) (29.5 %)
B9 WT WT p.G12S (c.34G > A) (45.2 %)
B10 WT p.V600E (c.1799T > A) (36.9 %) WT

aIn parentheses it is indicated the percentage of allele frequency evaluated by means of Ion Torrent